http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6482853-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C327-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-22 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C327-34 |
| filingDate | 2000-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2002-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a93e6b5a1d532bb28bfa85968de2d248 |
| publicationDate | 2002-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-6482853-B1 |
| titleOfInvention | Lactate thiolester for cardiac energy resuscitation and prevention of reperfusion injury and use as an energy supplement during exercise and recovery |
| abstract | The invention comprises a novel lactate compound for two unique purposes: (1) cardiac energy resuscitation and the treatment or prevention of reperfusion injury following ischemia, and (2) the provision of a fuel energy source to humans and other mammals during exercise and recovery. The novel lactate compound is particularly a lactate thiolester. Preferably, the thiol is selected from a cysteine or a methionine amino acid. In a particularly preferred form, the compound is a lactate N-acetyl ethyl ester of the cysteine or methionine amino acid. The most preferred compound is lactate N-acetyl cysteine thiolester (LNACE):Further, the invention involves use of mixtures of lactate- and pyruvate compounds as well as hexoses (glucose and fructose), maltodextrins and electrolytes as adjutants to support LNACE in its specific purposes. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9557334-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3505167-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9232815-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9808031-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9500657-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8927490-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007114791-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9897609-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7358277-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009285909-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004214892-A1 |
| priorityDate | 2000-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 173.